📣 VC round data is live. Check it out!

IHH Healthcare Valuation Multiples

Discover revenue and EBITDA valuation multiples for IHH Healthcare and similar public comparables like Dr. Sulaiman Al Habib, Rede D'Or São Luiz, Tenet Healthcare, Fresenius and more.

IHH Healthcare Overview

About IHH Healthcare

IHH Healthcare Bhd operates a network of healthcare clinics, hospitals, and postoperative rehabilitation centers. It also provides ancillary services, which include diagnostic laboratories, imaging centers, ambulatory care, and medical education facilities. The group’s reportable segments include Hospital and healthcare, Labs, PLife REIT, and Others. A majority of its revenue is generated from the Hospital and healthcare segment, which represents income generated from the provision of healthcare services through its hospitals and healthcare clinics across Singapore, Malaysia, India, Greater China, Turkiye and Europe, and Southeast Asia. Geographically, the group derives maximum revenue from Turkiye and Europe.


Founded

2010

HQ

Malaysia

Employees

70.0K

Financials (LTM)

Revenue: $7B
EBITDA: $2B

EV

$23B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

IHH Healthcare Financials

IHH Healthcare reported last 12-month revenue of $7B and EBITDA of $2B.

In the same LTM period, IHH Healthcare generated $5B in gross profit, $2B in EBITDA, and $545M in net income.

Revenue (LTM)


IHH Healthcare P&L

In the most recent fiscal year, IHH Healthcare reported revenue of $7B and EBITDA of $2B.

IHH Healthcare is profitable as of last fiscal year, with gross margin of 70%, EBITDA margin of 24%, and net margin of 8%.

See analyst estimates for IHH Healthcare
LTMLast FY202320242025202620272028
Revenue$7B$7B$5B$6B$7B
Gross Profit$5B$5B$4B$4B$5B
Gross Margin71%70%70%72%72%
EBITDA$2B$2B$2B$2B$2B
EBITDA Margin22%24%30%26%25%
EBIT Margin15%15%20%16%15%
Net Profit$545M$531M$746M$671M$531M
Net Margin8%8%14%11%8%
Net Debt—$3B———

Financial data powered by Morningstar, Inc.

IHH Healthcare Stock Performance

IHH Healthcare has current market cap of $20B, and enterprise value of $23B.

Market Cap Evolution


IHH Healthcare's stock price is $2.26.

IHH Healthcare share price increased by 1.4% in the last 30 days, and by 28.7% in the last year.

IHH Healthcare has an EPS (earnings per share) of $0.06.

See more trading valuation data for IHH Healthcare
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$23B$20B0.6%1.4%-1.9%28.7%$0.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

IHH Healthcare Valuation Multiples

IHH Healthcare trades at 3.4x EV/Revenue multiple, and 15.4x EV/EBITDA.

See NTM and 2027E valuation multiples for IHH Healthcare

EV / Revenue (LTM)


IHH Healthcare Financial Valuation Multiples

As of May 23, 2026, IHH Healthcare has market cap of $20B and EV of $23B.

IHH Healthcare has a P/E ratio of 36.7x.

LTMLast FY202320242025202620272028
EV/Revenue3.4x3.5x4.4x3.8x3.6x
EV/EBITDA15.4x14.6x14.8x14.7x14.6x
EV/EBIT22.7x23.4x21.7x23.7x23.6x
EV/Gross Profit4.8x5.0x6.3x5.3x5.0x
P/E36.7x37.7x26.8x29.8x37.7x
EV/FCF36.4x39.7x50.9x88.4x48.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified IHH Healthcare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

IHH Healthcare Margins & Growth Rates

IHH Healthcare grew revenue by 7% but EBITDA decreased by 1% in the last fiscal year.

In the most recent fiscal year, IHH Healthcare reported gross margin of 70%, EBITDA margin of 24%, and net margin of 8%.

See estimated margins and future growth rates for IHH Healthcare

IHH Healthcare Margins

Last FY202420252026202720282029
Gross Margin70%72%72%71%
EBITDA Margin24%26%25%22%
EBIT Margin15%16%15%15%
Net Margin8%11%8%8%
FCF Margin9%4%7%10%

IHH Healthcare Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth7%16%6%10%
Gross Profit Growth9%19%5%9%
EBITDA Growth(1%)0%1%(1%)
EBIT Growth8%(8%)0%9%
Net Profit Growth7%(10%)(21%)7%
FCF Growth24%(42%)81%52%

Data powered by FactSet, Inc. and Morningstar, Inc.

IHH Healthcare Operational KPIs

IHH Healthcare's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

IHH Healthcare's Rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

IHH Healthcare's Rule of X is 46% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for IHH Healthcare
LTMLast FY202320242025202620272028
Rule of 4030%32%———
Bessemer Rule of X42%46%———
Revenue per Employee—$0.1M———
Opex per Employee—$0.1M———
Opex to Revenue—55%50%56%57%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

IHH Healthcare Competitors

IHH Healthcare competitors include Dr. Sulaiman Al Habib, Rede D'Or São Luiz, Tenet Healthcare, Fresenius, DaVita, Aier EYE Hospital Group, Apollo Hospitals, Encompass Health, Max Healthcare Institute and Mayapada Hospital.

Most IHH Healthcare public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Dr. Sulaiman Al Habib6.1x5.8x23.6x23.7x
Rede D'Or São Luiz1.6x1.5x7.2x8.2x
Tenet Healthcare1.2x1.2x5.5x5.5x
Fresenius1.3x1.3x8.1x8.0x
DaVita1.9x1.8x9.0x8.9x
Aier EYE Hospital Group3.9x3.7x13.2x12.8x
Apollo Hospitals5.0x4.9x31.7x32.7x
Encompass Health2.2x2.1x9.3x10.0x

This data is available for Pro users. Sign up to see all IHH Healthcare competitors and their valuation data.

Start Free Trial

IHH Healthcare M&A Activity

IHH Healthcare has acquired 5 companies to date.

Last acquisition by IHH Healthcare was on September 4th 2024. IHH Healthcare acquired Island Hospital for $862M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by IHH Healthcare

Island Hospital
Angsana Molecular & Diagnostics Laboratory
Gleneagles Global Hospitals
Continental Hospitals
Description
Island Hospital is a Penang-based multispecialty healthcare provider offering diagnostics, surgery, and oncology services. Equipped with 1.5 Tesla MRI scanners, PET-CT units, and robotic surgery systems, it treats cardiology, orthopedics, and fertility cases. The 600-bed facility serves Malaysia and international patients from Indonesia and the Middle East, accredited by MSQH and JCI standards.
Angsana Molecular & Diagnostics Laboratory is a Singapore-headquartered multinational developer of genomic assays targeting conditions prevalent among Asian populations, including oncology, infectious diseases, cardiovascular disorders, and metabolic issues. It supplies clinicians with molecular diagnostics, interpretive consultations, and guidance for precision medicine therapies based on genetic profiling.
Gleneagles Global Hospitals is a Chennai-headquartered chain under IHH Healthcare, operating five multi-specialty facilities with 1,100 beds in Hyderabad, Bangalore, Chennai, and Mumbai, plus three feeder centers. The group excels in organ transplantation for liver, heart, lung, kidney, and bone marrow, performing over 3,000 transplants since inception. Plans include expansion to 1,900 beds, serving patients from India and abroad through partnerships with Parkway Pantai.
Continental Hospitals is a multi-specialty healthcare provider operating facilities in Gachibowli and Yuan, Hyderabad, India. The network delivers comprehensive services in orthopedics, oncology, cardiology, gastroenterology, and neurosurgery, equipped with advanced technologies like robotic surgery systems and linear accelerators for radiation therapy. It maintains NABH accreditation and serves patients through outpatient clinics, inpatient wards, and 24/7 emergency care. Continental Hospitals also features dedicated centers for pediatrics, IVF, and organ transplants.
HQ CountryMalaysiaSingaporeIndiaIndia
HQ City
Penang
Singapore
Hyderabad
Hyderabad
Deal Date4 Sep 20241 Aug 201728 Aug 201524 Mar 2015
Valuation$862M$13M$194M$89M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all IHH Healthcare acquisitions and their M&A valuation multiples.

Start Free Trial

IHH Healthcare Investment Activity

IHH Healthcare has invested in 4 companies to date.

Latest investment by IHH Healthcare was on January 29th 2026. IHH Healthcare invested in TibaRay in their Strategic investment round.

See VC round multiples

Latest Investments by IHH Healthcare

TibaRay
Doctor Anywhere
Us2.ai
Doctor Anywhere
Description
TibaRay creates ultra-fast, precise technologies to improve cancer diagnosis and treatment accuracy.
Doctor Anywhere is a Singapore-headquartered telehealth provider delivering video consultations, medicine delivery, and chronic care plans across Southeast Asia. The app connects users to GPs in Singapore, Malaysia, and Thailand for 24/7 access. Founded in 2017, it partners with clinics like Fullerton Health.
Us2.ai is a Singapore-based company creating AI software for echocardiography analysis. Its tools automate measurements from heart ultrasound scans and deliver online results to clinicians. Us2.ai supports cardiac centers globally, simplifying workflows and improving diagnostic precision.
Doctor Anywhere is a Singapore-headquartered telehealth provider delivering video consultations, medicine delivery, and chronic care plans across Southeast Asia. The app connects users to GPs in Singapore, Malaysia, and Thailand for 24/7 access. Founded in 2017, it partners with clinics like Fullerton Health.
HQ CountryUnited StatesSingaporeSingaporeSingapore
HQ City
—
Singapore
Singapore
Singapore
Deal Date29 Jan 202621 Dec 202214 Apr 202231 Mar 2020
RoundStrategic investmentSeries CSeries ASeries B
Raisedundisclosed$39M$15M$27M
InvestorsIHH HealthcareAsia Partners Fund Management; EDBI; IHH Healthcare; Kamet Capital Partners; Novo Holdings; OSK-SBI Venture Partners; Square Peg CapitalEDBI; FJ Labs; HEAL Partners; IHH Healthcare; Pappas Capital; Partech Ventures; Peak XV Partners; Sequoia CapitalEDBI; IHH Healthcare; Kamet Capital Partners; Pavilion Capital; Square Peg Capital
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all IHH Healthcare investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About IHH Healthcare

When was IHH Healthcare founded?IHH Healthcare was founded in 2010.
Where is IHH Healthcare headquartered?IHH Healthcare is headquartered in Malaysia.
How many employees does IHH Healthcare have?As of today, IHH Healthcare has over 70K employees.
Is IHH Healthcare publicly listed?Yes, IHH Healthcare is a public company listed on Bursa Malaysia.
What is the stock symbol of IHH Healthcare?IHH Healthcare trades under 5225 ticker.
When did IHH Healthcare go public?IHH Healthcare went public in 2012.
Who are competitors of IHH Healthcare?IHH Healthcare main competitors include Dr. Sulaiman Al Habib, Rede D'Or São Luiz, Tenet Healthcare, Fresenius, DaVita, Aier EYE Hospital Group, Apollo Hospitals, Encompass Health, Max Healthcare Institute, Mayapada Hospital.
What is the current market cap of IHH Healthcare?IHH Healthcare's current market cap is $20B.
What is the current revenue of IHH Healthcare?IHH Healthcare's last 12 months revenue is $7B.
What is the current revenue growth of IHH Healthcare?IHH Healthcare revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of IHH Healthcare?Current revenue multiple of IHH Healthcare is 3.4x.
Is IHH Healthcare profitable?Yes, IHH Healthcare is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of IHH Healthcare?IHH Healthcare's last 12 months EBITDA is $2B.
What is IHH Healthcare's EBITDA margin?IHH Healthcare's last 12 months EBITDA margin is 22%.
What is the current EV/EBITDA multiple of IHH Healthcare?Current EBITDA multiple of IHH Healthcare is 15.4x.
What is the current FCF of IHH Healthcare?IHH Healthcare's last 12 months FCF is $642M.
What is IHH Healthcare's FCF margin?IHH Healthcare's last 12 months FCF margin is 9%.
What is the current EV/FCF multiple of IHH Healthcare?Current FCF multiple of IHH Healthcare is 36.4x.
How many companies IHH Healthcare has acquired to date?As of May 2026, IHH Healthcare has acquired 5 companies.
What was the largest acquisition by IHH Healthcare?$862M acquisition of Island Hospital on 4th September 2024 was the largest M&A IHH Healthcare has done to date.
What companies IHH Healthcare acquired?IHH Healthcare acquired Island Hospital, Gleneagles Global Hospitals, Fortis Healthcare, Continental Hospitals, and Angsana Molecular & Diagnostics Laboratory.
In how many companies IHH Healthcare has invested to date?As of May 2026, IHH Healthcare has invested in 4 companies.
What was the last IHH Healthcare investment?On 29th January 2026 IHH Healthcare invested in TibaRay, participating in a Strategic investment round.
In what companies IHH Healthcare invested in?IHH Healthcare invested in Doctor Anywhere, Lucence Health, Us2.ai, and TibaRay.

See public comps similar to IHH Healthcare

Lists including IHH Healthcare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial